The invention provides an anti-restenotic drug for use in a method of reducing restenosis with a bioresorbable drug delivery stent, the method comprising: providing a drug delivery bioresorbable stent with a dosage of the anti-restenotic drug arranged within a plurality of openings in the stent without coating an exterior surface of the stent with the anti-restenotic drug implanting the stent within an artery of a patient and delivering the anti-restenotic drug from the stent to the artery at a minimum release rate of 1 percent of the total dosage of the drug on the stent per day throughout an entire administration period from the time of implantation of the stent until the time that substantially all the drug is released from the stent.
